Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACOMITINIB vs DANAZOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACOMITINIB vs DANAZOL: Safety Overview

Metric DACOMITINIB DANAZOL
Total FAERS Reports 682 477
Deaths Reported 325 71
Death Rate 47.7% 14.9%
Hospitalizations 168 142
Average Patient Age 64.0 yrs 51.7 yrs
% Female Patients 52.0% 34.9%
FDA Approval Date Sep 27, 2018 Approved Prior to Jan 1, 1982
Manufacturer Pfizer Laboratories Div Pfizer Inc Teva Pharmaceuticals USA, Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued